Glucose-Nacl B.Braun Melsungen

Glucose‑NaCl, marketed by B. Braun Melsungen, is an intravenous solution that combines sodium chloride and glucose monohydrate. The preparation is supplied in a sterile liquid form for infusion, with the exact concentration of each component not publicly disclosed. It is intended for fluid and electrolyte replacement and to provide an energy source during parenteral therapy. It is authorized for use in the European Union and is available by prescription only.

Glucose‑NaCl is used in clinical settings where intravenous fluid therapy is required.

- Maintenance of fluid balance in patients unable to take oral fluids. - Replacement of sodium and chloride losses due to surgery, trauma, or gastrointestinal drainage. - Provision of a carbohydrate source for patients receiving parenteral nutrition. - Support during peri‑operative care to prevent hypovolemia. - Dilution and administration of certain intravenous medications.

Adverse reactions to Glucose‑NaCl are generally infrequent, but they may occur during or after infusion.

Common: - Mild irritation or erythema at the catheter insertion site. - Temporary elevation of blood glucose levels, particularly in patients with diabetes or impaired glucose tolerance. - Small rise in serum sodium concentration that usually resolves without intervention. - Occasional nausea, light‑headedness, or mild headache during infusion.

Serious: - Significant hypernatremia that may produce confusion, seizures, or coma. - Allergic responses ranging from urticaria and angioedema to full‑body anaphylactic shock. - Fluid overload leading to peripheral edema, pulmonary congestion, or cardiac strain. - Development of metabolic acidosis in patients with compromised renal function.

When prescribing or administering Glucose‑NaCl, clinicians should observe several precautionary measures to ensure patient safety.

- Assess baseline electrolyte and glucose levels before initiation. - Adjust infusion rate in patients with renal insufficiency or heart failure. - Monitor fluid balance and weight to avoid overload. - Use caution in neonates, infants, and the elderly due to altered metabolism. - Avoid rapid bolus administration unless specifically indicated. - Verify compatibility with other IV solutions before mixing.

Glucose‑NaCl may interact with other intravenous agents or systemic medications; awareness of these interactions helps prevent complications.

Avoid: - Co‑administration with hypertonic saline solutions, which can cause excessive sodium load. - Simultaneous infusion of drugs that are incompatible with glucose solutions (e.g., certain antibiotics).

Use with caution: - Concurrent use of diuretics, which may amplify electrolyte shifts. - Administration alongside insulin therapy, requiring close glucose monitoring. - Patients receiving corticosteroids, as they may increase sodium retention.